finasteride has been researched along with Drug Withdrawal Symptoms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barcella, M; Borghi, E; Borgo, F; Diviccaro, S; Garcia-Segura, LM; Giatti, S; Melcangi, RC; Trejo, JL | 1 |
| Chopde, CT; Thakre, PP; Tundulwar, MR; Ugale, RR | 1 |
| Beadles-Bohling, AS; Crabbe, JC; Finn, DA; Ford, MM; Gililland-Kaufman, KR; Mark, GP; Snelling, C; Tanchuck, MA | 1 |
| Duque-Estrada, B; Piraccini, BM; Sisti, A; Tosti, A | 1 |
| Finn, DA; Kaufman, KR; Strong, MN; Tanchuck, MA | 1 |
| Gangisetty, O; Gould, J; Reddy, DS | 1 |
| Iorizzo, M; Tosti, A; Vincenzi, C | 1 |
| Crabbe, JC; Finn, DA; Long, SL; Tanchuck, MA | 1 |
| Crabbe, JC; Finn, DA; Gorin, RE; Long, SL; Tanchuck, MA | 1 |
| Finn, DA; Gorin-Meyer, RE; Long, SL; Tanchuck, MA; Wiren, KM; Yoneyama, N | 1 |
| Chopde, CT; Hirani, K; Kokare, DM; Sharma, AN; Ugale, RR | 1 |
| Beckley, EH; Finn, DA | 1 |
| Kim, HY; Reddy, DS; Rogawski, MA | 1 |
1 review(s) available for finasteride and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Hair loss in women.
Topics: Alopecia; Biotin; Contraceptives, Oral, Hormonal; Female; Finasteride; Gonadal Steroid Hormones; Hair Follicle; Humans; Iron; Iron Deficiencies; Minoxidil; Pregnancy; Pregnancy Complications; Puerperal Disorders; Stress, Psychological; Substance Withdrawal Syndrome; Trichotillomania | 2009 |
12 other study(ies) available for finasteride and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition.
Topics: 5-alpha Reductase Inhibitors; Animals; Astrocytes; Brain; Cholestenone 5 alpha-Reductase; Dentate Gyrus; Depression; Finasteride; Gastrointestinal Microbiome; Hippocampus; Male; Neurogenesis; Neuroimmunomodulation; Neurons; Rats; Rats, Sprague-Dawley; Steroids; Substance Withdrawal Syndrome | 2019 |
Neurosteroid allopregnanolone attenuates development of nicotine withdrawal behavior in mice.
Topics: Animals; Anxiety; Finasteride; Indomethacin; Male; Maze Learning; Mice; Motor Activity; Neurotransmitter Agents; Nicotine; Pregnanolone; Progesterone; Substance Withdrawal Syndrome; Time Factors | 2013 |
The neurosteroid environment in the hippocampus exerts bi-directional effects on seizure susceptibility in mice.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Alcohol-Induced Disorders, Nervous System; Animals; Anticonvulsants; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epilepsy; Finasteride; Genetic Predisposition to Disease; Hippocampus; Mice; Mice, Transgenic; Neurons; Pentylenetetrazole; Pregnanolone; Substance Withdrawal Syndrome | 2008 |
Replacement with GABAergic steroid precursors restores the acute ethanol withdrawal profile in adrenalectomy/gonadectomy mice.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Acute Disease; Alcohol-Induced Disorders, Nervous System; Animals; Castration; Central Nervous System Depressants; Desoxycorticosterone; Disease Models, Animal; Enzyme Inhibitors; Ethanol; Female; Finasteride; gamma-Aminobutyric Acid; Male; Mice; Neural Inhibition; Neurotransmitter Agents; Pregnanolone; Progesterone; Receptors, GABA-A; Substance Withdrawal Syndrome | 2010 |
A mouse kindling model of perimenstrual catamenial epilepsy.
Topics: 5-alpha Reductase Inhibitors; Animals; Diazepam; Disease Models, Animal; Epilepsy; Female; Finasteride; Gonadotropins; Hippocampus; Kindling, Neurologic; Menstrual Cycle; Mice; Mice, Inbred C57BL; Pregnanolone; Progesterone; Rats; Real-Time Polymerase Chain Reaction; Receptors, GABA-A; RNA, Messenger; Substance Withdrawal Syndrome | 2012 |
Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
Topics: Administration, Oral; Administration, Topical; Adult; Alopecia; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Minoxidil; Substance Withdrawal Syndrome; Vasodilator Agents | 2003 |
Interaction of chronic ethanol exposure and finasteride: sex and strain differences.
Topics: Animals; Area Under Curve; Ethanol; Female; Finasteride; Male; Mice; Pregnanolone; Sex Characteristics; Species Specificity; Substance Withdrawal Syndrome | 2004 |
Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines.
Topics: Alcohol Withdrawal Seizures; Animals; Behavior, Animal; Cholestenone 5 alpha-Reductase; Disease Models, Animal; Enzyme Inhibitors; Ethanol; Finasteride; Handling, Psychological; Male; Mice; Mice, Inbred Strains; Receptors, GABA; Seizures; Severity of Illness Index; Substance Withdrawal Syndrome | 2005 |
Sex differences in the effect of finasteride on acute ethanol withdrawal severity in C57BL/6J and DBA/2J mice.
Topics: Acute Disease; Animals; Central Nervous System Depressants; Corticosterone; Data Interpretation, Statistical; Enzyme Inhibitors; Estradiol; Ethanol; Female; Finasteride; Handling, Psychological; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Radioimmunoassay; Seizures; Sex Characteristics; Species Specificity; Steroid Hydroxylases; Substance Withdrawal Syndrome | 2007 |
Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats.
Topics: Animals; Anxiety; Central Nervous System Depressants; Dehydroepiandrosterone Sulfate; Drug Tolerance; Enzyme Inhibitors; Ethanol; Finasteride; Pregnanolone; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Substance Withdrawal Syndrome | 2007 |
Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility.
Topics: 5-alpha Reductase Inhibitors; Animals; Depression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Finasteride; Mice; Mice, Inbred DBA; Motor Activity; Pregnanolone; Progesterone; Substance Withdrawal Syndrome; Swimming | 2007 |
Neurosteroid withdrawal model of perimenstrual catamenial epilepsy.
Topics: 20-alpha-Dihydroprogesterone; Adult; Animals; Behavior, Animal; Disease Models, Animal; Disease Susceptibility; Epilepsy; Female; Finasteride; Gonadotropins, Equine; Humans; Menstrual Cycle; Pentylenetetrazole; Pregnanolone; Progesterone; Pseudopregnancy; Rats; Rats, Sprague-Dawley; Receptors, GABA; Steroids; Substance Withdrawal Syndrome | 2001 |